Breakthrough Study Suggests Possible Reversal of Alzheimer’s in Mice
Recent research from University Hospitals Cleveland Medical Center has unveiled a potential method to reverse Alzheimer’s disease symptoms, at least in laboratory mice. The study indicates that boosting a crucial energy molecule in the brain may reverse changes linked to the disease, including cognitive decline.
Researchers investigating two mouse models of Alzheimer’s, along with human brain samples, discovered significant drops in a molecule called NAD+ (Nicotinamide adenine dinucleotide), which is vital for energy production and cell health. As people age, levels of NAD+ naturally decrease, affecting how cells function and maintain themselves.
According to Dr. Andrew A. Pieper, who led the study, when NAD+ levels drop too low, brain cells struggle to perform necessary functions. “This raises concerns about overall brain health and maintenance,” he explained.
Dr. Charles Brenner, a scientist specializing in NAD+ research, pointed out the molecule’s importance for the brain, which consumes about 20% of the body’s total energy. He stated that this energy is crucial for brain functions and adaptability under stress.
In the Cleveland study, researchers employed a compound named P7C3-A20 to restore NAD+ levels in mice. Remarkably, this restored levels not only blocked the start of Alzheimer’s but also reversed the buildup of amyloid and tau proteins, which are hallmarks of the disease. Treated mice displayed improvements in cognitive function, and their blood showed normalized levels of tau, an important marker in Alzheimer’s research.
Historically, Alzheimer’s has been viewed as an irreversible condition. However, Dr. Pieper emphasized that their findings provide proof that some forms of dementia might be reversible.
The researchers noted that they were surprised by the degree to which Alzheimer’s symptoms improved in the mice once NAD+ levels were balanced, even though amyloid plaques were not directly targeted. This has led them to hope that similar strategies could eventually help people.
While the results are promising, researchers caution that these findings are preliminary and were based on animal models. Dr. Pieper reminded that Alzheimer’s disease is complicated, and what works in mice may not necessarily work in humans.
Furthermore, they expressed caution regarding NAD+ supplements available over-the-counter, which could lead to excessively high NAD+ levels—potentially increasing cancer risks according to some studies. The compound used in the study, P7C3-A20, however, allows cells to maintain healthier NAD+ levels during stress without leading to excess.
For those interested in brain health, Dr. Pieper recommends several proven lifestyle strategies. These include ensuring adequate sleep, following healthy diets like MIND or Mediterranean, staying active both mentally and physically, maintaining social ties, protecting against head injuries, and managing cardiovascular health risks.
The research team plans to continue exploring how energy levels in the brain affect cognitive health and whether their strategy can be effective against other age-related brain diseases.
Overall, this study opens the door to a more hopeful future for tackling Alzheimer’s and enhancing brain function as we age.
